Melanocortin 1 receptor ligands and methods of use

Date
2016-09-13
Authors
David L. Morse
Victor J. Hruby
Jonathan L. Sessler
Robert J. Gillies
Josef Vagner
Kevin N. Sill
Natalie M. Barkey
Narges K. Tafreshi
Christian Preihs
Journal Title
Journal ISSN
Volume Title
Publisher
United States Patent and Trademark Office
Abstract

The subject invention pertains to a modified MC1R peptide ligand comprising a peptide that is a melanocortin 1 receptor (MC1R) ligand and a functionality or linker, such as a click functionality, for conjugation to a surface or agent. The modified MC1R peptide ligand can be coupled, e.g., via a click reaction with a complementary click functionality attached, to a moiety to form an MC1R-targeted agent. Drugs, contrast agents, polymers, particles, micelles, surfaces of larger structures, or other moieties can be targeted to the MC1R. The subject invention also pertains to a MC1R peptide ligand-micelle complex comprising a peptide that is a melanocortin 1 receptor ligand connected via a click reaction product to a micelle. The micelle is stable in vivo and can target melanoma tumor cells by association of the peptide ligand with the MC1R or the tumor and selectively provide a detectable and/or therapeutic agent (such as an imageable contrast agent and/or anti-cancer agent) selectively to the tumor cell.

Description
Keywords
Citation